Study ID: CD-LAQ-201
Study Title
- Laquinimod Phase IIa Study in Active Crohn's Disease
Teva Identifier
- CD-LAQ-201
ClinicalTrials.gov Identifier
- NCT00737932
Study Status
- Completed
Trial Condition(s)
- Crohn's Disease
Interventions
- Drug: Laquinimod | Other: placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 75 Years
Trial Duration
- 05/01/2010 - 12/01/2011
Phase
- Phase 2
Study Type
Interventional